Global Japanese Encephalitis Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
LPI (LP Information)' newest research report, the “Japanese Encephalitis Vaccines Industry Forecast” looks at past sales and reviews total world Japanese Encephalitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Japanese Encephalitis Vaccines sales for 2023 through 2029. With Japanese Encephalitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Japanese Encephalitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Japanese Encephalitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Japanese Encephalitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Japanese Encephalitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Japanese Encephalitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Japanese Encephalitis Vaccines.
The global Japanese Encephalitis Vaccines market size is projected to grow from US$ 204 million in 2022 to US$ 295.7 million in 2029; it is expected to grow at a CAGR of 295.7 from 2023 to 2029.
United States market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Japanese Encephalitis Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Japanese Encephalitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Japanese Encephalitis Vaccines market?
What factors are driving Japanese Encephalitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Japanese Encephalitis Vaccines market opportunities vary by end market size?
How does Japanese Encephalitis Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
LPI (LP Information)' newest research report, the “Japanese Encephalitis Vaccines Industry Forecast” looks at past sales and reviews total world Japanese Encephalitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Japanese Encephalitis Vaccines sales for 2023 through 2029. With Japanese Encephalitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Japanese Encephalitis Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Japanese Encephalitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Japanese Encephalitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Japanese Encephalitis Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Japanese Encephalitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Japanese Encephalitis Vaccines.
The global Japanese Encephalitis Vaccines market size is projected to grow from US$ 204 million in 2022 to US$ 295.7 million in 2029; it is expected to grow at a CAGR of 295.7 from 2023 to 2029.
United States market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Japanese Encephalitis Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Japanese Encephalitis Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Attenuated Vaccines
- Inactivated Vaccines
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GlaxoSmithKline
- Bharat Biotech
- China National Biotec Group
- Valneva Products
What is the 10-year outlook for the global Japanese Encephalitis Vaccines market?
What factors are driving Japanese Encephalitis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Japanese Encephalitis Vaccines market opportunities vary by end market size?
How does Japanese Encephalitis Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Japanese Encephalitis Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Japanese Encephalitis Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Japanese Encephalitis Vaccines Segment by Type
2.2.1 Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.3 Japanese Encephalitis Vaccines Sales by Type
2.3.1 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Japanese Encephalitis Vaccines Sale Price by Type (2018-2023)
2.4 Japanese Encephalitis Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Japanese Encephalitis Vaccines Sales by Application
2.5.1 Global Japanese Encephalitis Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Japanese Encephalitis Vaccines Sale Price by Application (2018-2023)
3 GLOBAL JAPANESE ENCEPHALITIS VACCINES BY COMPANY
3.1 Global Japanese Encephalitis Vaccines Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Japanese Encephalitis Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Company (2018-2023)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Japanese Encephalitis Vaccines Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Vaccines Product Location Distribution
3.4.2 Players Japanese Encephalitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Japanese Encephalitis Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Japanese Encephalitis Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Japanese Encephalitis Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Japanese Encephalitis Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Japanese Encephalitis Vaccines Sales Growth
4.4 APAC Japanese Encephalitis Vaccines Sales Growth
4.5 Europe Japanese Encephalitis Vaccines Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Vaccines Sales by Country
5.1.1 Americas Japanese Encephalitis Vaccines Sales by Country (2018-2023)
5.1.2 Americas Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
5.2 Americas Japanese Encephalitis Vaccines Sales by Type
5.3 Americas Japanese Encephalitis Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Vaccines Sales by Region
6.1.1 APAC Japanese Encephalitis Vaccines Sales by Region (2018-2023)
6.1.2 APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2023)
6.2 APAC Japanese Encephalitis Vaccines Sales by Type
6.3 APAC Japanese Encephalitis Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Vaccines by Country
7.1.1 Europe Japanese Encephalitis Vaccines Sales by Country (2018-2023)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
7.2 Europe Japanese Encephalitis Vaccines Sales by Type
7.3 Europe Japanese Encephalitis Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Vaccines by Country
8.1.1 Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Japanese Encephalitis Vaccines Sales by Type
8.3 Middle East & Africa Japanese Encephalitis Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines
10.3 Manufacturing Process Analysis of Japanese Encephalitis Vaccines
10.4 Industry Chain Structure of Japanese Encephalitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Vaccines Distributors
11.3 Japanese Encephalitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Vaccines Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Vaccines Forecast by Region (2024-2029)
12.1.2 Global Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Japanese Encephalitis Vaccines Forecast by Type
12.7 Global Japanese Encephalitis Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Valneva Products
13.5.1 Valneva Products Company Information
13.5.2 Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Valneva Products Main Business Overview
13.5.5 Valneva Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Japanese Encephalitis Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Japanese Encephalitis Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Japanese Encephalitis Vaccines Segment by Type
2.2.1 Attenuated Vaccines
2.2.2 Inactivated Vaccines
2.3 Japanese Encephalitis Vaccines Sales by Type
2.3.1 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Japanese Encephalitis Vaccines Sale Price by Type (2018-2023)
2.4 Japanese Encephalitis Vaccines Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Japanese Encephalitis Vaccines Sales by Application
2.5.1 Global Japanese Encephalitis Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Japanese Encephalitis Vaccines Sale Price by Application (2018-2023)
3 GLOBAL JAPANESE ENCEPHALITIS VACCINES BY COMPANY
3.1 Global Japanese Encephalitis Vaccines Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Japanese Encephalitis Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Company (2018-2023)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Japanese Encephalitis Vaccines Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Vaccines Product Location Distribution
3.4.2 Players Japanese Encephalitis Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Japanese Encephalitis Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Japanese Encephalitis Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Japanese Encephalitis Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Japanese Encephalitis Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Japanese Encephalitis Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Japanese Encephalitis Vaccines Sales Growth
4.4 APAC Japanese Encephalitis Vaccines Sales Growth
4.5 Europe Japanese Encephalitis Vaccines Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Vaccines Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Vaccines Sales by Country
5.1.1 Americas Japanese Encephalitis Vaccines Sales by Country (2018-2023)
5.1.2 Americas Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
5.2 Americas Japanese Encephalitis Vaccines Sales by Type
5.3 Americas Japanese Encephalitis Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Vaccines Sales by Region
6.1.1 APAC Japanese Encephalitis Vaccines Sales by Region (2018-2023)
6.1.2 APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2023)
6.2 APAC Japanese Encephalitis Vaccines Sales by Type
6.3 APAC Japanese Encephalitis Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Vaccines by Country
7.1.1 Europe Japanese Encephalitis Vaccines Sales by Country (2018-2023)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
7.2 Europe Japanese Encephalitis Vaccines Sales by Type
7.3 Europe Japanese Encephalitis Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Vaccines by Country
8.1.1 Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Japanese Encephalitis Vaccines Sales by Type
8.3 Middle East & Africa Japanese Encephalitis Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines
10.3 Manufacturing Process Analysis of Japanese Encephalitis Vaccines
10.4 Industry Chain Structure of Japanese Encephalitis Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Vaccines Distributors
11.3 Japanese Encephalitis Vaccines Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS VACCINES BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Vaccines Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Vaccines Forecast by Region (2024-2029)
12.1.2 Global Japanese Encephalitis Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Japanese Encephalitis Vaccines Forecast by Type
12.7 Global Japanese Encephalitis Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Valneva Products
13.5.1 Valneva Products Company Information
13.5.2 Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
13.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Valneva Products Main Business Overview
13.5.5 Valneva Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Japanese Encephalitis Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Japanese Encephalitis Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Global Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 6. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Japanese Encephalitis Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Japanese Encephalitis Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 11. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Japanese Encephalitis Vaccines Revenue by Application (2018-2023)
Table 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Japanese Encephalitis Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 15. Global Japanese Encephalitis Vaccines Sales by Company (2018-2023) & (K Doses)
Table 16. Global Japanese Encephalitis Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Japanese Encephalitis Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Japanese Encephalitis Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 20. Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Vaccines Products Offered
Table 22. Japanese Encephalitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Japanese Encephalitis Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Japanese Encephalitis Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Japanese Encephalitis Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Japanese Encephalitis Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Japanese Encephalitis Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Japanese Encephalitis Vaccines Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Japanese Encephalitis Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Japanese Encephalitis Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Vaccines
Table 58. Key Market Challenges & Risks of Japanese Encephalitis Vaccines
Table 59. Key Industry Trends of Japanese Encephalitis Vaccines
Table 60. Japanese Encephalitis Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Japanese Encephalitis Vaccines Distributors List
Table 63. Japanese Encephalitis Vaccines Customer List
Table 64. Global Japanese Encephalitis Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Japanese Encephalitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Japanese Encephalitis Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Japanese Encephalitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Japanese Encephalitis Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Japanese Encephalitis Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Japanese Encephalitis Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Japanese Encephalitis Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 80. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. GlaxoSmithKline Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 85. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Latest Developments
Table 88. Bharat Biotech Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 90. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 91. Bharat Biotech Main Business
Table 92. Bharat Biotech Latest Developments
Table 93. China National Biotec Group Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 95. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 96. China National Biotec Group Main Business
Table 97. China National Biotec Group Latest Developments
Table 98. Valneva Products Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 100. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 101. Valneva Products Main Business
Table 102. Valneva Products Latest Developments
Table 1. Japanese Encephalitis Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Japanese Encephalitis Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Attenuated Vaccines
Table 4. Major Players of Inactivated Vaccines
Table 5. Global Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 6. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Japanese Encephalitis Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Japanese Encephalitis Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 11. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Japanese Encephalitis Vaccines Revenue by Application (2018-2023)
Table 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Japanese Encephalitis Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 15. Global Japanese Encephalitis Vaccines Sales by Company (2018-2023) & (K Doses)
Table 16. Global Japanese Encephalitis Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Japanese Encephalitis Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Japanese Encephalitis Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 20. Key Manufacturers Japanese Encephalitis Vaccines Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Vaccines Products Offered
Table 22. Japanese Encephalitis Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Japanese Encephalitis Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Japanese Encephalitis Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Japanese Encephalitis Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Japanese Encephalitis Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Japanese Encephalitis Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Japanese Encephalitis Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Japanese Encephalitis Vaccines Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Japanese Encephalitis Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Japanese Encephalitis Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Japanese Encephalitis Vaccines Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Japanese Encephalitis Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Japanese Encephalitis Vaccines Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Japanese Encephalitis Vaccines Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Vaccines
Table 58. Key Market Challenges & Risks of Japanese Encephalitis Vaccines
Table 59. Key Industry Trends of Japanese Encephalitis Vaccines
Table 60. Japanese Encephalitis Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Japanese Encephalitis Vaccines Distributors List
Table 63. Japanese Encephalitis Vaccines Customer List
Table 64. Global Japanese Encephalitis Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Japanese Encephalitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Japanese Encephalitis Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Japanese Encephalitis Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Japanese Encephalitis Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Japanese Encephalitis Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Japanese Encephalitis Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Japanese Encephalitis Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Japanese Encephalitis Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Japanese Encephalitis Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 80. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. GlaxoSmithKline Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 85. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Latest Developments
Table 88. Bharat Biotech Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 90. Bharat Biotech Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 91. Bharat Biotech Main Business
Table 92. Bharat Biotech Latest Developments
Table 93. China National Biotec Group Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 95. China National Biotec Group Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 96. China National Biotec Group Main Business
Table 97. China National Biotec Group Latest Developments
Table 98. Valneva Products Basic Information, Japanese Encephalitis Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Products Japanese Encephalitis Vaccines Product Portfolios and Specifications
Table 100. Valneva Products Japanese Encephalitis Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 101. Valneva Products Main Business
Table 102. Valneva Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Japanese Encephalitis Vaccines
Figure 2. Japanese Encephalitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Japanese Encephalitis Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Japanese Encephalitis Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2022
Figure 12. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Japanese Encephalitis Vaccines Consumed in Adults
Figure 14. Global Japanese Encephalitis Vaccines Market: Adults (2018-2023) & (K Doses)
Figure 15. Japanese Encephalitis Vaccines Consumed in Children
Figure 16. Global Japanese Encephalitis Vaccines Market: Children (2018-2023) & (K Doses)
Figure 17. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2022)
Figure 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Application in 2022
Figure 19. Japanese Encephalitis Vaccines Sales Market by Company in 2022 (K Doses)
Figure 20. Global Japanese Encephalitis Vaccines Sales Market Share by Company in 2022
Figure 21. Japanese Encephalitis Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Japanese Encephalitis Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 26. Americas Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 28. APAC Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 30. Europe Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 32. Middle East & Africa Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Japanese Encephalitis Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Japanese Encephalitis Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Japanese Encephalitis Vaccines
Figure 72. Industry Chain Structure of Japanese Encephalitis Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Japanese Encephalitis Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Japanese Encephalitis Vaccines
Figure 2. Japanese Encephalitis Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Japanese Encephalitis Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Japanese Encephalitis Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Attenuated Vaccines
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Global Japanese Encephalitis Vaccines Sales Market Share by Type in 2022
Figure 12. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Japanese Encephalitis Vaccines Consumed in Adults
Figure 14. Global Japanese Encephalitis Vaccines Market: Adults (2018-2023) & (K Doses)
Figure 15. Japanese Encephalitis Vaccines Consumed in Children
Figure 16. Global Japanese Encephalitis Vaccines Market: Children (2018-2023) & (K Doses)
Figure 17. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2022)
Figure 18. Global Japanese Encephalitis Vaccines Revenue Market Share by Application in 2022
Figure 19. Japanese Encephalitis Vaccines Sales Market by Company in 2022 (K Doses)
Figure 20. Global Japanese Encephalitis Vaccines Sales Market Share by Company in 2022
Figure 21. Japanese Encephalitis Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Japanese Encephalitis Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Japanese Encephalitis Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 26. Americas Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 28. APAC Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 30. Europe Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Japanese Encephalitis Vaccines Sales 2018-2023 (K Doses)
Figure 32. Middle East & Africa Japanese Encephalitis Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Japanese Encephalitis Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Japanese Encephalitis Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Japanese Encephalitis Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Japanese Encephalitis Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Japanese Encephalitis Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Japanese Encephalitis Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Japanese Encephalitis Vaccines
Figure 72. Industry Chain Structure of Japanese Encephalitis Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Japanese Encephalitis Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Japanese Encephalitis Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Japanese Encephalitis Vaccines Revenue Market Share Forecast by Application (2024-2029)
